Markets
Moderna’s cancer-vaccine breakthrough drives broad biopharma stock rally
Shares of Moderna MRNA) and Merck MRK) are soaring Wednesday after the companies reported a potentially historic breakthrough for their personalized mRNA cancer vaccine, intismeran autogene (V940/mRNA-4157), in combinat…